Malta - English - Medicines Authority

fresenius kabi limited cestrian court, eastgate way, manor park, runcorn, cheshire wa7 1nt, united kingdom - remifentanil - powder for concentrate for solution for infusion or injection - remifentanil 1 mg - anesthetics

Malta - English - Medicines Authority

fresenius kabi limited cestrian court, eastgate way, manor park, runcorn, cheshire wa7 1nt, united kingdom - remifentanil - powder for concentrate for solution for infusion or injection - remifentanil 2 mg - anesthetics

Malta - English - Medicines Authority

fresenius kabi limited cestrian court, eastgate way, manor park, runcorn, cheshire wa7 1nt, united kingdom - remifentanil - powder for concentrate for solution for infusion or injection - remifentanil 5 mg - anesthetics

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - remifentanil hydrochloride, quantity: 5.5 iu/mg (equivalent: remifentanil, qty 5 mg) - injection, powder for - excipient ingredients: glycine; nitrogen; hydrochloric acid - -as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults.,-as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical but not cardiac procedures in children aged 1 to 12 years.,-for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery -,when endotracheal intubation and controlled ventilation are anticipated.,-for provision of analgesia and sedation in mechanically ventilated intensive care patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - remifentanil hydrochloride 1.097mg equivalent to 1 mg remifentanil - powder for injection - 1 mg - active: remifentanil hydrochloride 1.097mg equivalent to 1 mg remifentanil excipient: glycine hydrochloric acid - remifentanil-aft is indicated as an analgesic agent: · for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery · for the continuation of analgesia in the immediate post-operative period during transition to longer acting analgesia · for the provision of analgesia and sedation in mechanically ventilated intensive care patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - remifentanil hydrochloride 2.194mg equivalent to 2 mg remifentanil - powder for injection - 2 mg - active: remifentanil hydrochloride 2.194mg equivalent to 2 mg remifentanil excipient: glycine hydrochloric acid - remifentanil-aft is indicated as an analgesic agent: · for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery · for the continuation of analgesia in the immediate post-operative period during transition to longer acting analgesia · for the provision of analgesia and sedation in mechanically ventilated intensive care patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - remifentanil hydrochloride 5.485mg equivalent to 5 mg remifentanil - powder for injection - 5 mg - active: remifentanil hydrochloride 5.485mg equivalent to 5 mg remifentanil excipient: glycine hydrochloric acid - remifentanil-aft is indicated as an analgesic agent: · for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery · for the continuation of analgesia in the immediate post-operative period during transition to longer acting analgesia · for the provision of analgesia and sedation in mechanically ventilated intensive care patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

hameln pharma pty ltd - alfentanil hydrochloride, quantity: 5.438 mg (equivalent: alfentanil, qty 5 mg) - injection, solution - excipient ingredients: sodium chloride; dilute hydrochloric acid; water for injections - alfentanil-hameln is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil-hameln is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil-hameln is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil-hameln or by adapting the infusion rate.

Australia - English - Department of Health (Therapeutic Goods Administration)

hameln pharma pty ltd - alfentanil hydrochloride, quantity: 1.0876 mg (equivalent: alfentanil, qty 1 mg) - injection, solution - excipient ingredients: sodium chloride; dilute hydrochloric acid; water for injections - alfentanil-hameln is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil-hameln is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil-hameln is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil-hameln or by adapting the infusion rate.

Ireland - English - HPRA (Health Products Regulatory Authority)

as kalceks - alfentanil - solution for injection/infusion - 500 microgram(s)/millilitre - alfentanil